# Evaluation of FLEXOFYTOL® Versus PLACEBO

> **NCT02909621** · NA · COMPLETED · sponsor: **Tilman S.A.** · enrollment: 150 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DIETARY_SUPPLEMENT:** FLEXOFYTOL®
- **OTHER:** PLACEBO

## Key facts

- **NCT ID:** NCT02909621
- **Lead sponsor:** Tilman S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2017-07
- **Final completion:** 2017-11
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02909621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02909621, "Evaluation of FLEXOFYTOL® Versus PLACEBO". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT02909621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*